Synthetic Biology Market Projected to Reach USD 214.34 Billion by 2033

The global synthetic biology market is poised for significant expansion, growing from USD 30.70 billion in 2024 to an estimated USD 214.34 billion by 2033. This growth, characterized by a compound annual growth rate of 24.1% starting in 2025, is driven by robust applications across the healthcare, agriculture, and energy sectors. As the industry addresses global challenges such as fossil fuel depletion and chronic diseases, synthetic biology is becoming a critical tool for sustainable development and medical innovation.

The global synthetic biology market is undergoing a massive transformation, with its valuation expected to rise from USD 30.70 billion in 2024 to USD 214.34 billion by 2033. This growth is underpinned by a projected CAGR of 24.1% beginning in 2025, when the market is estimated to reach USD 38.10 billion. Key drivers for this expansion include the urgent need for sustainable solutions to the energy crisis and fossil fuel depletion, as well as the technology's ability to mitigate pollution through the development of biofuels that do not produce toxic gases upon combustion.

Technical segmentation reveals that the oligonucleotide synthetic segment dominated the market in 2024 and is poised for continued leadership. This dominance is fueled by escalating demand for synthetic DNA, RNA, and genes within diagnostic centers, supported by significant government investments in pharmaceutical and biotechnology R&D. While oligonucleotides lead in share, the enzyme segment is projected to be the fastest-growing component of the market, and enabling technologies remain a primary driver of the sector's overall technical progress.

The industry's landscape is shaped by major players such as Thermo Fisher Scientific, Inc., Dupont, Amyris, Inc., and Genscript USA, Inc., alongside others like Novozymes and Integrated DNA Technologies (IDT). These organizations are applying synthetic biology to diverse fields, from modifying crop genomes for faster agricultural production to developing potential cancer cures by addressing infinite cell division. As the market matures through 2033, these applications in healthcare, chemicals, and agriculture are expected to maintain robust growth across various global regions.